TY - JOUR
T1 - Viral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41
AU - Ashkenazi, Avraham
AU - Viard, Mathias
AU - Wexler-Cohen, Yael
AU - Blumenthal, Robert
AU - Shai, Yechiel
N1 - Israel Science Foundation; National Cancer Institute, U.S. National Institutes of Health (NIH) [HHSN26120080001E]; NIH, National Cancer Institute, Center for Cancer ResearchThe authors thank Batya Zarmi for her valuable help with peptide purification, Dr. Ayala Sharp and Eitan Ariel, and the staff of the flow cytometry unit at the Weizmann Institute of Science for their valuable technical assistance and advice. This study was supported by the Israel Science Foundation and also has been funded, in part, with federal funds from the National Cancer Institute, U.S. National Institutes of Health (NIH), under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does it mention any trade names, commercial products, or organizations or imply endorsement by the U. S. Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. Y.S. is the incumbent of the Harold S. and Harriet B. Brady Professorial Chair in Cancer Research.
PY - 2011/7
Y1 - 2011/7
N2 - Fusion of human immunodeficiency virus (HIV-1) with target cells is mediated by the gp41 transmembrane envelope protein. The loop region within gp41 contains 2 crucial cysteines that play an unknown role in HIV-cell fusion. On the basis of cell-cell fusion assay, using human T-cell lines [Jurkat E6-1 and Jurkat HXBc2(4)], and virus-cell fusion assay, using fully infectious HIV-1 HXBc2 virus and TZM-bl human cell line, we provide evidence that the oxidation state of the disulfide bond within a loop domain peptide determines its activity. The oxidized (closed) form inhibits fusion, while the reduced (opened) form enhances hemifusion. These opposite activities reach 60% difference in viral fusion. Both forms of the loop domain interact with gp41: the opened form enhances gp41 folding into a bundle, whereas the closed form inhibits this folding. Therefore, the transformation of the cysteines from a reduced to an oxidized state enables the loop to convert from opened to closed conformations, which assists gp41 to fold and induces hemifusion. The significant conservation of the loop region within many envelope proteins suggests a general mechanism, which is exploited by viruses to enhance entry into their host cells.
AB - Fusion of human immunodeficiency virus (HIV-1) with target cells is mediated by the gp41 transmembrane envelope protein. The loop region within gp41 contains 2 crucial cysteines that play an unknown role in HIV-cell fusion. On the basis of cell-cell fusion assay, using human T-cell lines [Jurkat E6-1 and Jurkat HXBc2(4)], and virus-cell fusion assay, using fully infectious HIV-1 HXBc2 virus and TZM-bl human cell line, we provide evidence that the oxidation state of the disulfide bond within a loop domain peptide determines its activity. The oxidized (closed) form inhibits fusion, while the reduced (opened) form enhances hemifusion. These opposite activities reach 60% difference in viral fusion. Both forms of the loop domain interact with gp41: the opened form enhances gp41 folding into a bundle, whereas the closed form inhibits this folding. Therefore, the transformation of the cysteines from a reduced to an oxidized state enables the loop to convert from opened to closed conformations, which assists gp41 to fold and induces hemifusion. The significant conservation of the loop region within many envelope proteins suggests a general mechanism, which is exploited by viruses to enhance entry into their host cells.
KW - HIV-1 fusion inhibitor
KW - Peptide-membrane interaction
UR - http://www.scopus.com/inward/record.url?scp=79960193477&partnerID=8YFLogxK
U2 - https://doi.org/10.1096/fj.10-175752
DO - https://doi.org/10.1096/fj.10-175752
M3 - مقالة
C2 - 21429941
SN - 0892-6638
VL - 25
SP - 2156
EP - 2166
JO - FASEB Journal
JF - FASEB Journal
IS - 7
ER -